Teleflex Incorporated · NYSE:TFX

Teleflex — Q4 2007 Earnings Presentation

28 slides from Teleflex's earnings presentation, Feb 29, 2008

  1. Slide 1: Teleflex Incorporated Q4 and Year-End 2007 Financial Results

    Teleflex Incorporated Q4 and Year-End 2007 Financial Results February 29, 2008 Exhibit 99.1

  2. Slide 2: Forward-Looking Statements/Additional Notes

    Forward-Looking Statements/Additional Notes This presentation and our discussion contain forward-looking information and statements including, but not limited to, such matters as business strategies, market trends, future financial performance, forecast of diluted earnings per share, forecast of cas

  3. Slide 3: Conference Call Logistics

    Conference Call Logistics The release, accompanying slides, and replay webcast available online at www.teleflex.com (click on "Investors") Telephone replay available by dialing 888-286-8010 or for international calls, 617-801-6888, pass code number 30859245

  4. Slide 4: Jeff Black, Chairman and Chief Executive Officer

    Jeff Black Chairman and Chief Executive Officer

  5. Slide 5: Full Year 2007 Summary

    Full Year 2007 Summary Redefined portfolio for greater consistency, improved margins, sustainable growth Created over $1.5 billion medical technology business with Arrow acquisition Divested ~$860 million Auto and Industrial business Gain on sale, net of tax of approximately $108 million Utilized ne

  6. Slide 6: Earnings per Share Excluding Special Charges from Continuing Operations

    Earnings per Share Excluding Special Charges from Continuing Operations $3.70 - $3.90 21% Growth 14% - 20% Growth 16% Growth Note: GAAP Earnings (Loss) per Share are as follows for the applicable periods: 2006: $2.40 2007: ($1.08) 2008: $3.03 - $3.30

  7. Slide 7: Teleflex Fourth Quarter Objectives

    Teleflex Fourth Quarter Objectives Complete automotive and industrial business divestiture Utilize net proceeds from acquisition to pay-down debt Execute on Arrow International integration activities Accelerate regulatory compliance program to respond to Arrow FDA corporate warning letter Realize be

  8. Slide 8: Fourth Quarter Summary

    Fourth Quarter Summary Continuing operations deliver solid results Gross Margins improve 450 bps over prior year Operating margins before special charges of 14.4%, up 100 bps Medical adjusted segment operating margins exceed 19% Aerospace segment operating margins return to 12% range Commercial segm

  9. Slide 9: Fourth Quarter Business Dynamics

    Fourth Quarter Business Dynamics Teleflex Medical Teleflex Commercial Teleflex Aerospace Medical Sales up on acquisitions; Arrow growth of 6% International markets lead sales growth Strong surgical device sales in North America, decline in alternate site sales Asia, Canada, Latin America - sales up

  10. Slide 10: Kevin Gordon, Executive Vice President and Chief Financial Officer

    Kevin Gordon Executive Vice President and Chief Financial Officer

  11. Slide 11: Three Month Summary from Continuing Operations

    Three Month Summary from Continuing Operations

  12. Slide 12: Three Month Summary from Continuing Operations

    Three Month Summary from Continuing Operations Note: Q4'07 (Gains)/Losses and other charges includes write-off of $3.4m financing costs, net of tax

  13. Slide 13: Full Year Summary from Continuing Operations

    Full Year Summary from Continuing Operations

  14. Slide 14: Full Year Summary from Continuing Operations

    Full Year Summary from Continuing Operations Note: FY'07 (Gains)/Losses and other charges includes write-off of $3.4m financing costs, net of tax

  15. Slide 15: Cash Flow From Continuing Operations

    Cash Flow From Continuing Operations ($ Millions) Note: Free Cash Flow defined as Cash Flow from Operations less Capital Expenditures and Dividends 43% Growth 67% Growth Capital Expenditures - $40.8 million; Dividends - $44.1 million Capital Expenditures - $44.7 million; Dividends - $48.9 million

  16. Slide 16: Net Debt Trend

    Net Debt Trend ($ Millions) Pre-Arrow Acquisition Post-Arrow Acquisition Post- Auto/Industrial Divestiture

  17. Slide 17: Medical Segment FY'07 vs. FY'06 Commentary

    Medical Segment FY'07 vs. FY'06 Commentary European Markets Anesthesia & urology sales lead growth Favorable currency impact North American Markets Acquisitions drive growth Q4 core growth impacted by negative comparison with 2006 which had one additional week Decline in alternate site product lines

  18. Slide 18: Aerospace Segment FY'07 vs. FY'06 Commentary

    Aerospace Segment FY'07 vs. FY'06 Commentary Repair Products and Services: Phase out of lower margin product lines Impact of a customer insourcing Restructuring/cost savings create margin improvement Cargo Handling: Acquisition adds $11M to Q4 revenues Delivered more wide body cargo systems Increase

  19. Slide 19: Commercial Segment FY'07 vs. FY'06 Commentary

    Commercial Segment FY'07 vs. FY'06 Commentary Continuing Commercial Businesses: Marine aftermarket and international sales strength Marine cost controls, pricing, and currency improve profitability Marine profit improvement in Q4 Loss in power systems Rigging services growth due to acquisition Margi

  20. Slide 20: 2008 Outlook

    Low High Earnings per share from continuing operations including special charges $3.03 $3.30 Addback special charges1 $0.67 $0.60 Earnings per share from continuing operations before special charges $3.70 14% Growth $3.90 20% Growth 2008 Outlook Revenues of over $2.4 billion Overall segment operatin

  21. Slide 21: Jeff Black, Chairman and Chief Executive Officer

    Jeff Black Chairman and Chief Executive Officer

  22. Slide 22: 2008 Objectives

    2008 Objectives Teleflex Medical Teleflex Commercial Teleflex Aerospace Execute Arrow integration plans and achieve synergies Invest for core growth Medical R&D initiatives Engineering for new aircraft platforms New technologies Acquire to enhance product offerings Deliver strong cash flow and conti

  23. Slide 23: Question and Answer Session

    Question and Answer Session Teleflex

  24. Slide 24: Appendices

    Appendices Teleflex

  25. Slide 25: Appendix A - Capital Structure

    Appendix A - Capital Structure

  26. Slide 26: Appendix B - QTD Reconciliation of Medical Operating Profit and Margins

    Appendix B - QTD Reconciliation of Medical Operating Profit and Margins

  27. Slide 27: Appendix C - YTD Reconciliation of Medical Operating Profit and Margins

    Appendix C - YTD Reconciliation of Medical Operating Profit and Margins

  28. Slide 28: Appendix D - 2007 vs. 2006 Special Charge Income Statement Classification Summary

    Appendix D - 2007 vs. 2006 Special Charge Income Statement Classification Summary

Teleflex — Q4 2007 Earnings Presentation on 6ix